Livforsakringsbolaget Skandia’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,600
Closed -$69.2K 540
2025
Q1
$69.2K Hold
1,600
﹤0.01% 526
2024
Q4
$89.9K Hold
1,600
﹤0.01% 507
2024
Q3
$109K Buy
1,600
+1,400
+700% +$79K 0.01% 511
2024
Q2
$8.44K Hold
200
﹤0.01% 546
2024
Q1
$13.8K Hold
200
﹤0.01% 532
2023
Q4
$14.8K Hold
200
﹤0.01% 528
2023
Q3
$13.6K Hold
200
﹤0.01% 510
2023
Q2
$18.8K Hold
200
﹤0.01% 479
2023
Q1
$13.6K Hold
200
﹤0.01% 523
2022
Q4
$9.9K Hold
200
﹤0.01% 545
2022
Q3
$6K Sell
200
-1,000
-83% -$41.2K ﹤0.01% 561
2022
Q2
$47K Sell
1,200
-1,200
-50% -$64.2K ﹤0.01% 550
2022
Q1
$168K Hold
2,400
0.01% 494
2021
Q4
$187K Hold
2,400
0.01% 501
2021
Q3
$229K Hold
2,400
0.01% 490
2021
Q2
$298K Hold
2,400
0.02% 481
2021
Q1
$316K Hold
2,400
0.02% 410
2020
Q4
$318K Buy
2,400
+900
+60% +$109K 0.03% 396
2020
Q3
$153K Hold
1,500
0.02% 442
2020
Q2
$130K Hold
1,500
0.01% 467
2020
Q1
$87K Hold
1,500
0.01% 508
2019
Q4
$139K Hold
1,500
0.02% 437
2019
Q3
$136K Hold
1,500
0.02% 476
2019
Q2
$177K Buy
+1,500
New +$151K 0.02% 426

Other funds holding EXAS

Livforsakringsbolaget Skandia's EXAS Position: Q2 2025 in Review

Livforsakringsbolaget Skandia sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 1,600 shares — an estimated $69.2K sold.

Livforsakringsbolaget Skandia first reported a position in EXAS in Q2 2019 and held it in 24 quarters. The position peaked at $318K in Q4 2020. 559 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Livforsakringsbolaget Skandia reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 1,600 Exact Sciences shares in Q2 2025, an estimated $69.2K.
  • Livforsakringsbolaget Skandia first reported a position in Exact Sciences in Q2 2019 and held it in 24 quarters.
  • Livforsakringsbolaget Skandia's Exact Sciences position peaked at $318K in Q4 2020.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Livforsakringsbolaget Skandia's 13F filing for Q2 2025, filed 9 Jul 2025.